Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia

Código QR

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia

Morgan Anderson,1 Jason Powell,2 Kendall M Campbell,3 James R Taylor2 1North Florida/South Georgia Veterans Health System, Malcom Randall VAMC, 2University of Florida, College of Pharmacy, Gainesville, 3The Center for Underrepresented Minorities in Academic Medicine, The Florida State University Co...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anderson M, Powell J, Campbell KM, Taylor JR
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/6982535b6b804006b188f8e64cb0f52c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Pamela Kushner
Publicado: (2010)

A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes
por: April N Naegeli, et al.
Publicado: (2010)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Kushner P
Publicado: (2010)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
por: Kedia N
Publicado: (2011)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
por: Lorber D
Publicado: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Giuseppe Derosa, et al.
Publicado: (2009)

Evidence for the benefit of exercise therapy in patients with type 2 diabetes
por: Madden KM
Publicado: (2013)

Lorcaserin for weight management
por: Taylor JR, et al.
Publicado: (2013)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
por: Almigbal TH
Publicado: (2021)

Type 2 diabetes in Brazil: epidemiology and management
por: Almeida-Pititto B, et al.
Publicado: (2015)

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
por: Berlie H, et al.
Publicado: (2012)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
por: Nitzan O, et al.
Publicado: (2015)

Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
por: Basit A, et al.
Publicado: (2019)

Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
por: Mansouri D, et al.
Publicado: (2020)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Robert Moses
Publicado: (2009)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Joshua J Neumiller, et al.
Publicado: (2010)

Management of limited joint mobility in diabetic patients
por: Abate M, et al.
Publicado: (2013)

HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
por: Kowall B, et al.
Publicado: (2013)

Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
por: Malloy J, et al.
Publicado: (2012)

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
por: Sheri R Colberg, et al.
Publicado: (2010)

An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting
por: Courtney MR, et al.
Publicado: (2015)

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
por: Baptist Gallwitz
Publicado: (2010)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
por: AlMaatouq MA
Publicado: (2012)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
por: Amy Fleischman, et al.
Publicado: (2009)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
por: Al Sifri S
Publicado: (2012)

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
por: Thuillier P, et al.
Publicado: (2015)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Alaa Badawi, et al.
Publicado: (2010)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
por: Kim Y, et al.
Publicado: (2012)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
por: Ofori SN, et al.
Publicado: (2014)

Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
por: Sasakabe T, et al.
Publicado: (2011)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
por: Gregory E Peterson
Publicado: (2009)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
por: Ogedengbe OS, et al.
Publicado: (2015)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012)

Red cell distribution width in type 2 diabetic patients
por: Nada AM
Publicado: (2015)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Jean-Pierre Le Floch
Publicado: (2010)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
por: Sosale A, et al.
Publicado: (2015)

Emerging utility of once-weekly exenatide in patients with type 2 diabetes
por: Goud A, et al.
Publicado: (2015)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
por: Nishio S, et al.
Publicado: (2015)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Stanley S Schwartz
Publicado: (2010)